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Changes in Biochimica et Biophysica Acta a new elan 
The new, physical appearance of Biochimica et 
Biophysica Acta (BBA) is a reflection of the many 
changes introduced in BBA during the last two years. 
Changes to the editorial management of BBA and in 
the manuscript handling procedures, were aimed at 
further streamlining the reviewing process to ensure 
rapid publication. In addition, several new initiatives 
have been taken. 
The present distribution of responsibilities among 
the various sections is as follows: 
Bioenergetics Peter Rich and 
(including reviews M~xten Wikstrtim 
on Bioenergetics) 
Biomembranes Tony Lee 
and Reviews on 
Biomembranes 
1. Editorial structure 
In the rapidly expanding fields of biochemistry, 
biophysics, and molecular biology, selection of the 
best reviewers for any manuscript requires first hand, 
up-to-date knowledge of the field in question. For 
this reason each Executive Editor has now assumed 
responsibility for a particular section of BBA, con- 
trary to the situation before 1995, where all sections 
were under the general responsibility of the complete 
Board. In view of the size of the individual sections, 
two Executive Editors were appointed for each of the 
larger sections, and one ]Executive Editor each for the 
General Subjects ection and for the youngest BBA 
section, Molecular Basis of Disease. 
This decision implied an expansion of the Board of 
Executive Editors, a process which has taken place 
gradually during the last two years. We are now close 
to our goal and are very pleased to welcome several 
outstanding colleagues as new Executive Editors to 
BBA. These are, Joseph Avruch (Charlestown, MA), 
Minoru Fukuda (La Jolla, CA), Thomas Kreis 
(Geneva), Tony Lee (Southampton), Ylva Lindqvist 
(Stockholm), George Lorimer (Wilmington, DE), Pe- 
ter Rich (London), Jack Riordan (Scottsdale, AZ), 
Dennis Vance (Edmonton) and M~trten Wikstr~im 
(Helsinki). 
Lipids and Lipid 
Metabolism 
Henk van den Bosch 
and Dennis Vance 
Protein Structure 
and Molecular 
Enzymology 
Molecular Cell 
Research 
Ylva Lindqvist and 
George Lorimer 
Joseph Avruch and 
Thomas Kreis 
Gene Structure 
and Expression 
Molecular Basis 
of Disease 
Peter van der Vliet 
Jack Riordan 
General Subjects Minoru Fukuda 
Reviews on Cancer David Livingston 
In addition, Keith Tipton (Dublin) is Review Editor 
for the section Protein Structure and Molecular Enzy- 
mology and David Waxman assists the Boston office 
as Associate Executive Editor. 
We said farewell to a number of Executive Editors 
who have left our ranks after having served BBA in 
an outstanding manner for many years. Namely, Philip 
Cohen (Dundee) who was with the Journal from 
1982-1994 and was in charge of the receiving office 
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in Dundee; George Radda (Oxford) who was ap- 
pointed to the Board in 1976, being chairman from 
1989-1994. He set up and managed the Oxford 
office for many years; Gene Kennedy (Boston, MA) 
who served on the Board from 1985-1995 and was 
the driving force behind the establishment of the 
Boston office; Les Dutton (Philadelphia, PA), Board 
member from 1989-1996 and since 1981 involved 
with BBA as Editor of Reviews on Bioenergetics; 
Jeff Schatz (Basel), who influenced the Molecular 
Cell Research section from 1992-1995; Karel van 
Dam (Amsterdam), who spent twelve years, 1984- 
1996, steering and maintaining the high standard of 
the Bioenergetics section and Yasuo Kagawa 
(Tochigi), manager of the receiving office in Tochigi, 
Japan from 1990-1996. We are all much obliged to 
these colleagues who invested so much of their valu- 
able time in helping BBA retain its position as one of 
the world's most comprehensive biochemistry jour- 
nals. 
Changes occurred in the Editorial Board as well. It 
was decided to limit membership to six years in order 
to renew the Editorial Board on a regular basis and to 
bring in new expertise in rapidly expanding areas. 
This meant that we bade farewell to many of our 
loyal colleagues who have unfailingly helped us, 
some for more than twenty-five years, by reviewing 
or having manuscripts reviewed and who have pro- 
vided countless constructive suggestions for the con- 
tinual improvement of BBA. We have recently wel- 
comed several new members to the Editorial Board 
and in the coming period we plan to expand the 
Board further to number 100-120 Editors. This will 
enable us to cover most of the areas in an appropriate 
fashion. 
2. Rapid and stringent reviewing procedures 
The manuscript reviewing procedures are continu- 
ally being optimized. The Editorial Offices, in Ams- 
terdam and Boston, provide optimum support o the 
Executive Editors in the reviewing process, in order 
to ensure the best possible selection of reviewers. By 
using comprehensive r viewer databases, and avail- 
ing of the latest communication technology, the speed 
of the reviewing procedure is still increasing. During 
the last six months we have been successful, on 
average, in communicating a first decision to the 
authors of regular papers within six weeks of receipt 
of the manuscript. Even faster procedures were intro- 
duced recently for handling Rapid Reports, for which 
special significance and timeliness are the primary 
criteria for acceptance. Publication speed has been 
increased by skipping the proof stage. Rapid Reports 
can now be published within ten weeks. The selection 
of the most appropriate reviewers not only results in 
a prompt decision, but also increases the stringency 
of the reviewing process. Papers that do not advance 
our knowledge sufficiently are nowadays more easily 
rejected and this has led to a drop in the acceptance 
rate. Of every five papers submitted last year, only 
two were accepted. This meant a reduction of 20% 
compared to the previous years and will further in- 
crease the quality of the Journal. 
3. New initiatives 
BBA is well-known for its high-quality reviews 
with a high impact. Separate volumes of reviews on 
Biomembranes and Cancer are published, each hav- 
ing their own Editorial Advisory Board. In addition 
mini-reviews appear egularly in most other sections. 
We plan to increase the frequency of publication of 
these short, topical reviews on emerging technologies 
and new developments. Such critical reviews are 
intended as vehicles for expressing the personal opin- 
ion of the author ather than be exhaustive compila- 
tions of developments in an entire field. We also plan 
to publish a number of thematic issues. These issues 
will be guest-edited and contain invited papers on 
topics of special interest. Previous examples of such 
issues in BBA were the special issues on Mitochon- 
drial Diseases and on the European BioEnergetics 
Conference which proved to be very successful. An- 
other new development has been the introduction of 
the subsection on Lipids in Signalling and Recogni- 
tion on the initiative of Henk van den Bosch and 
Dennis Vance. This section focuses on extracellular 
signals, lipid mediators and lipid-derived messengers, 
hot areas in signal transduction. A more focused 
General Subjects section is also one of our goals. 
This section will concentrate on new developments in 
the growing area of Glycobiology, a field in which 
our new Executive Editor, Minoru Fukuda, excels. 
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Finally, under the inspired guidance of Editor David 
Livingston, Reviews on Cancer Online was recently 
launched on the World Wide Web. This review sec- 
tion aims to provide investigators with a fast and 
reliable source for reviewing the latest discoveries in 
the cancer esearch field. Not only does it contain the 
much acclaimed regular eview articles three months 
prior to their appearance in print but it also publishes 
meeting reports highlighting the most compelling 
conclusions, hortly after the actual meeting has taken 
place. In addition, Reviews on Cancer Online con- 
tains a discussion forum and an alerting service. It is 
freely available on the Internet at URL: 
h t tp : / /w  w w.e lsev ie r .n l / locate / roco /  or 
http: / /www.elsevier.com/locate/roco/  
Next year, BBA will celebrate its 50th anniversary 
(1947-1997). The year 1997 will witness a matured 
and at the same time rejuvenated BBA, alive and 
eager to continue publishing excellent manuscripts 
into the next century. Whether this will continue to 
be in the same paper format is doubtful, but one thing 
is clear: with capable and experienced staff in both 
the Amsterdam and Boston Editorial Offices, a re- 
newed Board of Executive Editors, a dynamic Edito- 
rial Board and a vast number of excellent reviewers 
world-wide we are convinced that we can continue 
serving the scientific community by reviewing and 
publishing manuscripts in a rapid, rigorous and fair 
manner, be it on paper or on-line. 
On behalf of the Executive Editors 
4. A journal making history 
BBA enjoys a long-sl~anding tradition in scientific 
publishing, receiving almost 4000 manuscripts each 
year. This number has been pretty stable over the 
years despite sharp competition due to the emergence 
of many new journals. 11: is only seven years ago that 
the golden Celebratory Volume 1000 was published 
witnessing the Journal's decisive role in the history 
of biochemistry, biophysics, and molecular biology. 
Currently, BBA progresses at an even more rapid 
pace; with one issue published every three days, 
volume 1317 being completed this year. 
f 
Peter C. van der Vliet 
(Editor-in-Chief) 
The photograph on the following page was taken 
at the last Executive Editors meeting, held in Boston, 
June 1996. 
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1. Tony Lee, 2. Les Dutton, 3. Thomas Kreis, 4. 
George Lorimer, 5. Yasuo Kagawa, 6. Karel van 
Dam, 7. Peter van der Vliet, 8. Jack Riordan, 9. Bill 
Slater, 10. Ylva Lindqvist, 11. David Waxman, 12. 
Ann O'Brien (Elsevier Science), 13. Henk van den 
Bosch, 14. Denise Wells (Elsevier Science), 15. Al- 
bert van der Weft (Elsevier Science), 16. Dennis 
Vance, 17. Bernard Aleva (Elsevier Science). Miss- 
ing from photo: Joe Avruch, M~rten WikstrCm, Mi- 
noru Fukuda and Peter Rich. 
